BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1186255)

  • 1. Adrenal steroidogenesis in "low renin" or hyporeninemic hypertension.
    Melby JC; Dale SL
    J Steroid Biochem; 1975 May; 6(5):761-6. PubMed ID: 1186255
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered adrenal steroidogenesis in "low renin" essential hypertension.
    Dale SL; Melby JC
    Trans Assoc Am Physicians; 1974; 87():248-57. PubMed ID: 4456734
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenocortical factors in hypertension. I. Significance of 18-hydroxy-11-deoxycorticosterone.
    Ulick S
    Am J Cardiol; 1976 Nov; 38(6):814-24. PubMed ID: 187051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial levels and mineralocorticoid activity of 18-hydroxy-11-deoxycorticosterone in the rat.
    Nicholls MG; Brown WC; Hay GD; Mason PA; Fraser R
    J Steroid Biochem; 1979 Jan; 10(1):67-70. PubMed ID: 513718
    [No Abstract]   [Full Text] [Related]  

  • 5. [Importance of the simultaneous estimation of aldosterone, 18-hydroxy-11-deoxycorticosterone and cortisol in the adrenal veins in arterial hypertension with suppressed renin (author's transl)].
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Sb Lek; 1977 Jan; 79(1):1-10. PubMed ID: 841259
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
    [No Abstract]   [Full Text] [Related]  

  • 7. 16alpha, 18-Dihydroxydeoxycorticosterone and the binding of aldosterone to mineralocorticoid receptors in kidney of adrenalectomized rats.
    Fuller PJ; Pressley L; Adam WR; Funder JW
    J Steroid Biochem; 1976 May; 7(5):387-90. PubMed ID: 180348
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of angiotensin II and saralasin on 18-hydroxy-11-deoxycorticosterone production by isolated human adrenal glomerulosa cells.
    Braley LM; Williams GH
    J Clin Endocrinol Metab; 1979 Oct; 49(4):600-3. PubMed ID: 479350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.
    Melby JC; Dale SL
    Mayo Clin Proc; 1977 May; 52(5):317-22. PubMed ID: 870774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro biosynthesis of 18-hydroxy-11-deoxycorticosterone from deoxycorticosterone by human adrenal glands removed from patients with hypercorticism.
    Touitou Y; Bogdan A; Luton JP
    Clin Endocrinol (Oxf); 1979 Jul; 11(1):39-45. PubMed ID: 519871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocorticosteroids in experimental and human hypertension.
    Melby SC; Dale SL
    J Endocrinol; 1979 May; 81(2):93P-106P. PubMed ID: 458347
    [No Abstract]   [Full Text] [Related]  

  • 12. Affinity of 18,19-dihydroxydeoxycorticosterone and 18-hydroxy-19-nor-deoxycorticosterone to aldosterone receptor and their mineralocorticoid activity.
    Okamoto M; Momoi K; Yamano T; Nakamura M; Odaguchi K; Shimizu T; Okada T; Terasawa T
    Biochem Int; 1983 Dec; 7(6):687-94. PubMed ID: 6237653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the ultrastructural and steroidogenic properties of mitochondria of fetal rat adrenals in tissue culture. A morphometric and a gas chromatographic analysis.
    Salmenperä M
    J Ultrastruct Res; 1976 Sep; 56(3):277-86. PubMed ID: 183003
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Synthesis of 18-oxygenated steroids in the rat adrenal cortex.
    Fattah DI; Whitehouse BJ; Vinson GP
    J Endocrinol; 1975 Jun; 65(3):50P-51P. PubMed ID: 1151251
    [No Abstract]   [Full Text] [Related]  

  • 15. [Deviation in steroid hormone secretion in essential hypertension].
    Ojima M
    Nihon Rinsho; 1979 Jun; 37(6):1275-82. PubMed ID: 158103
    [No Abstract]   [Full Text] [Related]  

  • 16. New mineralocorticoids and adrenocorticosteroids in hypertension.
    Melby JC; Dale SL
    Am J Cardiol; 1976 Nov; 38(6):805-13. PubMed ID: 136892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic aldosterone and 18-hydroxydeoxycorticosterone studies in labile and stable benign essential hypertension.
    Nowaczynski W; Kuchel O; Genest J; Messerli FH; Honda M; Tolis G; Seth K; Parvin-Pande R; Kubo S; Grose J; Ledoux F; Lebel M
    J Steroid Biochem; 1975 May; 6(5):767-78. PubMed ID: 171513
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenocortical factors in hypertension.
    Griffing GT; Melby JC
    J Clin Pharmacol; 1985; 25(5):318-27. PubMed ID: 3897295
    [No Abstract]   [Full Text] [Related]  

  • 19. The conversion of 18-hydroxycorticosterone and 18-hydroxy-11-deoxycorticosterone to aldosterone by rat adrenal tissue: evidence for an alternative biosynthetic pathway.
    Müller J
    J Steroid Biochem; 1980 Mar; 13(3):245-51. PubMed ID: 7392603
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of corticosteroid antibodies for the study of corticosteroid biosynthesis in vitro.
    Vecsei P; Onyechi R; Hornung J; Dietz R; Mast G; Hobler H
    J Steroid Biochem; 1975; 6(3-4):383-7. PubMed ID: 1186235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.